Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 3
2012 1
2013 6
2014 15
2015 11
2016 18
2017 12
2018 9
2019 17
2020 22
2021 8
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33020231

107 results
Results by year
Filters applied: . Clear all
Page 1
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215
Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.
Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P. Karfis I, et al. Oncotarget. 2020 Feb 11;11(6):589-599. doi: 10.18632/oncotarget.27460. eCollection 2020 Feb 11. Oncotarget. 2020. PMID: 32110279 Free PMC article.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page